相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
Hung-Jung Wang et al.
ONCOGENE (2019)
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models
Young K. Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
Richard J. Rebello et al.
GENES (2017)
KDM4B as a Target for Prostate Cancer: Structural Analysis and Selective Inhibition by a Novel Inhibitor
Chia-Han Chu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular Profiling of Prostatic Acinar Morphogenesis Identifies PDCD4 and KLF6 as Tissue Architecture-Specific Prognostic Markers in Prostate Cancer
Chi-Rong Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells
Shinzo Yamamoto et al.
CARCINOGENESIS (2013)
A Gene Expression Signature of Epithelial Tubulogenesis and a Role for ASPM in Pancreatic Tumor Progression
Wei-Yu Wang et al.
GASTROENTEROLOGY (2013)
The Trithorax Group Protein Ash2l Is Essential for Pluripotency and Maintaining Open Chromatin in Embryonic Stem Cells
Ma Wan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
Kelly Coffey et al.
NUCLEIC ACIDS RESEARCH (2013)
Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency
Yu Liang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C)
Ulrike Leurs et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Caffeic Acid Phenethyl Ester Suppresses the Proliferation of Human Prostate Cancer Cells through Inhibition of p70S6K and Akt Signaling Networks
Chih-Pin Chuu et al.
CANCER PREVENTION RESEARCH (2012)
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models
V. Harma et al.
ONCOGENE (2012)
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
Peter Hammarsten et al.
PLOS ONE (2012)
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
Weibo Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc
Chih-Pin Chuu et al.
CANCER SCIENCE (2011)
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Nima Mosammaparast et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
The Histone Demethylase JMJD2C Is Stage-Specifically Expressed in Preimplantation Mouse Embryos and Is Required for Embryonic Development
Jianle Wang et al.
BIOLOGY OF REPRODUCTION (2010)
Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors
Shohei Hamada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
Mark F. Ciaccio et al.
NATURE METHODS (2010)
Genetic Alterations and Changes in Expression of Histone Demethylases in Prostate Cancer
Hanna E. Suikki et al.
PROSTATE (2010)
Identification of non-histone substrates for JMJD2A-C histone demethylases
V. K. Chaithanya Ponnaluri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer Progression
Jason A. Reuter et al.
CANCER CELL (2009)
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2009)
Developmental roles of the histone lysine demethylases
Amanda Nottke et al.
DEVELOPMENT (2009)
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
Kanishka Sircar et al.
JOURNAL OF PATHOLOGY (2009)
Inhibition of vimentin or β1 integrin revert morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo
Xueping Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G. Liu et al.
ONCOGENE (2009)
Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
P. McCall et al.
BRITISH JOURNAL OF CANCER (2008)
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Bora Gurel et al.
MODERN PATHOLOGY (2008)
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
Sook Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression end Akt activation
Roble Bedolla et al.
CLINICAL CANCER RESEARCH (2007)
Three-dimensional culture models of normal and malignant breast epithelial cells
Genee Y. Lee et al.
NATURE METHODS (2007)
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Melanie Wissmann et al.
NATURE CELL BIOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
Lawrence True et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development
SS Grewal et al.
NATURE CELL BIOLOGY (2005)
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
C Grandori et al.
NATURE CELL BIOLOGY (2005)
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
A Arabi et al.
NATURE CELL BIOLOGY (2005)
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer
JI Kreisberg et al.
CANCER RESEARCH (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
G Ayala et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
